Pharmaceuticals, Biotechnology and Life Sciences
Dexpramipexole demonstrated significant reduction of eosinophil levels in blood and inflamed tissues PITTSBURGH–(BUSINESS WIRE)–#ALS–Knopp Biosciences LLC, a privately held drug…
Glenmark Pharmaceuticals got the final approval by the US FDA for its Ranolazine Extended-Release Tablets, generic version of Gilead’s Ranexa.
Providing researchers with an automated solution for two-step nucleic acid sample preparation DARESBURY, England–(BUSINESS WIRE)–Arcis Biotechnology (“Arcis”), the nucleic acid…
Karolinska Development’s drug developer Dilafor AB, focused on tafoxiparin for obstetric indications, has enrolled the first subject in its Phase 2b study with tafoxiparin in pregnant women planned for labor induction, Karolinska said Tuesday in a press release.
“The SWIFF-CAR system does precisely that, representing a major breakthrough in our ongoing efforts to develop innovative applications to treat a range of diseases, including cancer and autoimmune diseases.”
Dr. Reddy’s Laboratories today announced the launch of an over-the-counter (OTC) store-brand equivalent of Mucinex D Extended Release Tablets
LONDON–(BUSINESS WIRE)–EMMAC Life Sciences Ltd, the European independent medical cannabis company, is pleased to announce that it has formed a…
Boehringer Ingelheim today announced results from two paediatric studies of dabigatran etexilate, which were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne, Australia.
DUBLIN–(BUSINESS WIRE)–The “KAM Metrics: Measuring Success (2019)” report has been added to ResearchAndMarkets.com’s offering. Key Account Management teams are still…
Trial met its primary objective with imeglimin observed to have a favorable safety and tolerability profile in patients with type…